Last reviewed · How we verify

hydrocortisone 17-butyrate 0.1% Cream preparation

Wake Forest University · FDA-approved active Small molecule Quality 2/100

hydrocortisone 17-butyrate 0.1% Cream preparation is a Small molecule drug developed by Wake Forest University. It is currently FDA-approved. Also known as: Locoid, locoid.

At a glance

Generic namehydrocortisone 17-butyrate 0.1% Cream preparation
Also known asLocoid, locoid
SponsorWake Forest University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about hydrocortisone 17-butyrate 0.1% Cream preparation

What is hydrocortisone 17-butyrate 0.1% Cream preparation?

hydrocortisone 17-butyrate 0.1% Cream preparation is a Small molecule drug developed by Wake Forest University.

Who makes hydrocortisone 17-butyrate 0.1% Cream preparation?

hydrocortisone 17-butyrate 0.1% Cream preparation is developed and marketed by Wake Forest University (see full Wake Forest University pipeline at /company/wake-forest-university).

Is hydrocortisone 17-butyrate 0.1% Cream preparation also known as anything else?

hydrocortisone 17-butyrate 0.1% Cream preparation is also known as Locoid, locoid.

What development phase is hydrocortisone 17-butyrate 0.1% Cream preparation in?

hydrocortisone 17-butyrate 0.1% Cream preparation is FDA-approved (marketed).

Related